Urinary phytoestrogens and cancer, cardiovascular, and all-cause mortality in the continuous National Health and Nutrition Examination Survey

European Journal of Nutrition

Volumn 55, Issue 3, 2016, Pages 1029-1040

  Reger, Michael K ^a,b   Zollinger, Terrell W ^a   Liu, Ziyue ^a   Jones, Josette ^a   Zhang, Jianjun ^a,c  

^a INDIANA UNIVERSITY   (United States)

^b FERRIS STATE UNIVERSITY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Cardiovascular disease; Cohort study; Mortality; Urinary phytoestrogens

Indexed keywords

DAIDZEIN; ENTEROLACTONE; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; 2,3-BIS(3'-HYDROXYBENZYL)BUTYROLACTONE; BIOLOGICAL MARKER; GAMMA BUTYROLACTONE; LIGNAN;

ADULT; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR MORTALITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ESTROGEN URINE LEVEL; FEMALE; HAZARD RATIO; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TANDEM MASS SPECTROMETRY; ANALOGS AND DERIVATIVES; BODY MASS; CARDIOVASCULAR DISEASE; FOLLOW UP; MIDDLE AGED; MORTALITY; NEOPLASM; NUTRITION; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TREATMENT OUTCOME; URINE;

4-BUTYROLACTONE; ADULT; BIOMARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOFLAVONES; LIGNANS; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; NUTRITION SURVEYS; PHYTOESTROGENS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84928978445     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-015-0917-y     Document Type: Article

References (75)

1. Murphy SL, Xu J, Kochanek KD (2013) Deaths: final data for 2010. Centers for Disease Control and Prevention, Atlanta
2. World Health Organization (2013) The top 10 causes of death: Fact Sheet Number 310
3. Latest world cancer statistics—Press release number 223 (2013) World Health Organization, Lyon
4. Kuhnle GG, Dell’Aquila C, Low YL, Kussmaul M, Bingham SA (2007) Extraction and quantification of phytoestrogens in foods using automated solid-phase extraction and LC/MS/MS. Anal Chem 79(23):9234–9239
5. Horn-Ross PL, Barnes S, Lee M, Coward L, Mandel E, Koo K, John EM, Smith M (2000) Assessing phytoestrogen exposure in epidemiologic studies: development of a database (United States). Cancer Causes Control 11:299–302
6. Adlercreutz H (2007) Lignans and human health. Crit Rev Clin Lab Sci 44:483–525
7. Thomas BF, Zeisel SH, Busby MG, Hill JM, Mitchell RA, Scheffler NM, Brown SS, Bloeden LT, Dix KJ, Jeffcoat AR (2001) Quantitative analysis of the principle soy isoflavones genistein, daidzein and glycitein, and their primary conjugated metabolites in human plasma and urine using reversed-phase high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl 760(2):191–205
8. Griffiths K, Denis L, Turkes A, Morton MS (1998) Possible relationship between dietary factors and pathogenesis of prostate cancer. Int J Urol 5:195–213
9. Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA (2000) Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36:27–32
10. Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T, Mori M (2002) Is daidzein non-metabolizer a high risk for prostate cancer? A case–controlled study of serum soybean isoflavone concentration. Jpn J Clin Oncol 32(8):296–300
11. Lampe JW (2003) Isoflavonoid and lignan phytoestrogens as dietary biomarkers. J Nutr 133(Suppl):956S–964S
12. Ohno S, Nakajima Y, Inoue K, Nakazawa H, Nakajin S (2003) Genistein administration decreases serum corticosterone and testosterone levels in rats. Life Sci 74:733–742
13. Matori H, Umar S, Nadadur RD, Sharma S, Partow-Navid R, Afkhami M, Amjedi M, Eghbali M (2012) Genistein, a soy phytoestrogen, reverses severe pulmonary hypertension and prevents right heart failure in rats. Hypertension 60(2):425–430
14. Shi L, Ryan HH, Jones E, Simas TA, Lichenstein AH, Sun Q, Hayman LL (2014) Urinary isoflavone concentrations are inversely associated with cardiometabolic risk markers in pregnant U.S. women. J Nutr 144(3):344–351
15. Nicastro HL, Mondul AM, Rohrmann S, Platz EA (2013) Associations between urinary soy isoflavonoids and two inflammatory markers in the United States in 2005-2008. Cancer Causes Control 24(6):1185–1196
16. Branham WA, Dial SL, Moland CL, Hass BS, Blair RM, Fang H, Shi L, Tong W, Perkins RG, Sheehan DM (2002) Phytoestrogens and mycoestrogens bind to the rat uterine estrogen receptor. J Nutr 132(4):658–664
17. Holzbeierlein JM, McIntosh J, Thrasher JB (2005) The role of soy phytoestrogens in prostate cancer. Curr Opin Urol 15:17–22
18. Magee PJ, Rowland IR (2004) Phytoestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 91:513–531
19. Kuipper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139(10):4252–4263
20. Onozawa M, Fukuda K, Ohtani M, Akaza H, Sugimura T, Wakabayashi K (1998) Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell link LNCaP. Jpn J Clin Oncol 28:360–363
21. Turner JV, Agatonovic-Kustrin S, Glass BD (2007) Molecular aspects of phytoestrogen selective binding at estrogen receptors. J Pharm Sci 96(8):1879–1885
22. Weber KS, Setchell KD, Stocco DM, Lephart ED (2001) Dietary soy-phytoestrogens decrease testosterone levels and prostate weight without altering LH, prostate 5-alpha-reductase or testicular steroidogenic acute regulatory peptide levels in adult male Sprague-Dawley rats. J Endocrinol 170(3):591–599
23. Heald CL, Ritchie MR, Bolton-Smith C, Morton MS, Alexander FE (2007) Phyto-oestrogens and risk of prostate cancer in Scottish men. Br J Nutr 98:388–396
24. Hedelin M, Klint A, Chang ET, Bellocco R, Johansson JE, Andersson SO, Heinonen SM, Adlercreutz H, Adami HO, Gronberg H, Balter KA (2006) Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study. Cancer Causes Control 17:169–180
25. Ziegler RG (2004) Phytoestrogens and breast cancer. Am J Clin Nutr 79(2):183–184
26. Horn-Ross PL, John EM, Lee M, Stewart SL, Koo J, Sakoda LC, Shiau AC, Goldstein J, Davis P, Perez-Stable EJ (2001) Phytoestrogen consumption and breast cancer risk in a multiethnic population. Am J Epidemiol 154(5):434–441
27. van der Schouw YT, Kreijkamp-Kaspers S, Peeters PHM, Keinan-Boker L, Rimm EB, Grobbee DE (2005) Cardiovascular disease in women: prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in western women. Circulation 111(4):465–471
28. Lissin LW, Cooke JP (2000) Phytoestrogens and cardiovascular health. J Am Coll Cardiol 35(6):1403–1410
29. Adlercreutz H (2002) Phyto-oestrogens and cancer. Lancet Oncol 3:364–373
30. Anderson LN, Cotterchio M, Boucher BA, Kreiger N (2013) Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women. Int J Cancer 132:1683–1692
31. van der Schouw YT, Kreijkamp-Kaspers S, Peeters PH, Keinan-Boker L, Rimm EB, Grobbee DE (2005) Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in western women. Circulation 111:465–471
32. Seow A, Shi CY, Franke AA, Hankin JH, Lee HP, Yu MC (1998) Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle aged and older Chinese in Singapore. Cancer Epidemiol Biomarkers Prev 7:135–140
33. French MR, Thompson LU, Hawker GA (2007) Validation of a phytoestrogen food frequency questionnaire with urinary concentrations of isoflavones and lignan metabolites in premenopausal women. J Am Coll Nutr 26(1):76–82
34. Maskarinec G, Singh S, Meng L, Franke AA (1998) Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population. Cancer Epidemiol Biomarkers Prev 7(7):613–619
35. Jaceldo-Siegl K, Fraser GE, Chan J, Franke A, Sabate J (2008) Validation of soy protein estimates from a food-frequency questionnaire with repeated 24-h recalls and isoflavonoid excretion in overnight urine in a western population with a wide range of soy intakes. Am J Clin Nutr 87(5):1422–1427
36. Lampe JW, Gustafson DR, Hutchins AM, Martini MC, Li S, Wahala K, Grandits GA, Potter JD, Slavin JL (1999) Urinary isoflavonoid and lignan excretion on a western diet: relation to soy, vegetable, and fruit intake. Cancer Epidemiol Biomarkers Prev 8:699–707
37. NHANES (1999–2004) Public-use Linked Mortality Files (2006) (2013) National Health and Nutrition Examination Survey
38. NHANES 1999–2000 Public Data Release File Documentation (2000). US Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville
39. Analytic and Reporting Guidelines: The National Health and Nutrition Examination Survey (NHANES) (2006) Centers for Disease Control and Prevention, Hyattsville
40. Rybak ME, Parker DL, Pfeiffer CM (2008) Determination of urinary phytoestrogens by HPLC-MS/MS: a comparison of atmospheric pressure chemical ionization (APCI) and electrospray ionization (ESI). J Chromatogr B Analyt Technol Biomed Life Sci 861(1):145–150
41. Parker DL (2004) Division of laboratory sciences laboratory protocol: phytoestrogens. National Center for Health Statistics, Hyatsville
42. National Health and Nutrition Examination Survey (1999-2004) Linked Mortality Files (2009) Office of Analysis and Epidemiology, Hyatsville
43. Yu O, Eberg M, Benayoun S, Aprikian A, Barist G, Suissa S, Azoulay L (2014) Use of statins and the risk of death in patients with prostate cancer. J Clin Oncol 32(1):5–11
44. Van Hemelrijck M, Holmberg L, Garmo M, Hammar N, Walldium G, Binda E, Lambe M, Jungner I (2011) Association between levels of c-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS study. Cancer Epidemiol Biomarkers Prev 20(3):428–438
45. Ozasa K, Nakao M, Watanabe Y, Hayashi K, Miki T, Mikami K, Mori M, Sakauchi F, Washio M, Ito Y, Suzuki K, Wakai K, Tamakoshi A (2004) Serum phytoestrogens and prostate cancer risk in a nested case–control study among Japanese men. Cancer Sci 95(1):65–71
46. Kurahashi N, Iwasaki M, Inoue M, Sasazuki S, Tsugane S (2008) Plasma isoflavones and subsequent risk of prostate cancer in a nested case–control study: the Japan Public Health Center. J Clin Oncol 26:5923–5929
47. Verhaus M, van Gils CH, Keinan-Boker L, Grace PB, Bingham SA, Peeters PHM (2007) Plasma phytoestrogens and subsequent breast cancer risk. J Clin Oncol 25(6):648–655
48. Bylund A, Zhang J-X, Bergh A, Damber JE, Widmark A, Johnsson A, Adlercreutz H, Aman P, Shepherd MJ, Hallmans G (2000) Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice. Prostate 42:304–314
49. Goetzl MA, Van Veldhuizen PJ, Thrasher JB (2007) Effects of soy phytoestrogens on the prostate. Prostate Cancer Prostatic Dis 10:216–223
50. Rao CV, Wang C-X, Simi B, Lubet R, Kelloff G, Steele V, Reddy BS (1997) Enhancement of experimental colon cancer by genistein. Cancer Res 57:3717–3722
51. Jackson MD, McFarlane-Anderson ND, Simon GA, Bennett FI, Walker SP (2010) Urinary phytoestrogens and risk of prostate cancer in Jamaican men. Cancer Causes Control 21(12):2249–2257
52. Chen L-H, Fang J, Sun Z, Li H, Wu Y, Denmark-Wahnefried W, Lin X (2009) Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells. J Nutr 139(4):653–659
53. Penalvo JL, Lopez-Romero P (2012) Urinary enterolignan concentrations are positively associated with serum HDL cholesterol and negatively associated with serum triglycerides in U.S. adults. J Nutr 142(4):751–756
54. Vanharanta M, Voutilainen S, Lakka TA, van der Lee M, Adlercreutz H, Salonen JT (1999) Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case–control study. Lancet 354(9196):2112–2115
55. Peterson J, Dwyer J, Adlercreutz H, Scalbert A, Jacques P, McCullough ML (2010) Dietary lignans: physiology and potential for cardiovascular disease risk reduction. Nutr Rev 68(10):571–603
56. Frankenfeld CL (2014) Cardiometabolic risk factors are associated with high urinary enterolactone concentration, independent of urinary enterodiol concentration and dietary fiber intake in adults. J Nutr 144(9):1446–1453
57. Eichholzer M, Richard A, Nicastro HL, Platz EA, Linseisen J, Rohrmann S (2014) Urinary lignans and inflammatory markers in the US National Health and Nutrition Examination Survey (NHANES) 1999–2004 and 2005–2008. Cancer Causes Control 25(3):395–403
58. Struja T, Richard A, Linseisen J, Eichholzer M, Rohrmann S (2014) The association between urinary phytoestrogen excretion and components of the metabolic syndrome in NHANES. Eur J Nutr 53(6):1371–1381
59. Prasad K (2005) Hypocholesterolemic and antiantherosclerotic effect of flax lignan complex isolated from flaxseed. Atherosclerosis 179(2):269–275
60. Prasad K (2008) Regression of hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Atherosclerosis 197(1):34–42
61. Penumathsa SV, Koneru S, Thirunavukkarasu M, Zhan L, Prasad K, Maulik N (2007) Secoisolariciresinol diglucoside: relevance to angiogenesis and cardioprotection against ischemia-reperfusion injury. J Pharmacol Exp Ther 320(2):951–959
62. Carmeliet P, Ng YS, Nuyens D, Theilmeier G, Brusselmans K, Cornelissen I, Ehler E, Kakkar VV, Stalmans I, Mattot V, Perriard JC, Dewerchin M, Flameng W, Nagy A, Lupu F, Moons L, Collen D, D’Amore PA, Shima DT (1999) Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF 164 and VEGF188. Nat Med 5(5):495–502
63. Hodis HN, Mack WJ, Kono N, Azen SP, Shoupe D, Hwang-Levine J, Petitti D, Whitfield-Maxwell L, Yan M, Franke AA, Selzer RH (2011) Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial. Stroke 42:3168–3175
64. Li S-H, Liu X-X, Bai Y-Y, Wang X-J, Sun K, Chen J-Z, Hui R-T (2010) Effect of oral supplementation on vascular endothelial function in postmenopausal women: a meta-analysis of randomized placebo-controlled trials. Am J Clin Nutr 91(2):480–486
65. van der Schouw YT, Sampson L, Willett WC, Rimm EB (2005) The usual intake of lignans but not that of isoflavones may be related to cardiovascular risk factors in U.S. men. J Nutr 135(2):260–266
66. Kelly LA, O’Leary JJ, Seidlova-Wuttke D, Wuttke W, Norris LA (2010) Genistein alters coagulation gene expression in ovariectomised rats treated with phytoestrogens. Thromb Haemost 104:1250–1257
67. Liggins J, Mulligan A, Runswick S, Bingham SA (2002) Daidzein and genistein content of cereals. Eur J Clin Nutr 56:961–966
68. Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA (2000) Daidzein and genistein contents of vegetables. Br J Nutr 84:717–725
69. Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA (2000) Daidzein and genistein content of fruits and nuts. J Nutr Biochem 11(6):326–331
70. Rowland I, Faughnan M, Hoey L, Wahala K, Williamson G, Cassidy A (2003) Bioavailability of phyto-oestrogens. Br J Nutr 89:S45–S58
71. Bhaqwat S, Haytowitz DB, Holden JM (2008) USDA Database for the Isoflavone Content of Selected Foods, vol 2. Nutrient Data Laboratory, Beltsville
72. Park SY, Wilkens LR, Franke AA, Le Marchand L, Kakazu KK, Goodman MT, Murphy SP, Henderson BE, Kolonel LN (2009) Urinary phytoestrogen excretion and prostate cancer risk: a nested case–control study in the Multiethnic Cohort. Br J Cancer 101(1):185–191
73. Atkinson C, Skor HE, Fitzgibbons ED, Scholes D, Chen C, Wahala K, Schwartz SM, Lampe JW (2002) Overnight urinary isoflavone excretion in a population of women living in the United States, and its relationship to isoflavone intake. Cancer Epidemiol Biomarkers Prev 11:253–260
74. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL (2005) Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 113(2):192–200
75. Grace PB, Taylor JI, Low Y-L, Luben RN, Mulligan AA, Botting NP, Dowsett M, Welch AA, Khaw K-T, Wareham NJ, Day NE, Bingham SA (2004) Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European Prospective Investigation of Cancer and Nutrition-Norfolk. Cancer Epidemiol Biomarkers Prev 13(5):698–708